HLA-DP: A class II rescription molecules involved in epitope spreading during the development of the multiple sclerosis

Human Immunology

Volumn 59, Issue 1, 1998, Pages 15-24

  Yu, Min ^a   Kinkel, R Philip ^a   Weinstock Guttman, Bianca ^a   Cook, Daniel J ^a   Tuohy, Vincent K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; MYELIN BASIC PROTEIN;

ALLELE; ANTIGEN RECOGNITION; ARTICLE; CROSS REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; AUTOIMMUNE DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITOPE MAPPING; FEMALE; HLA-DP ANTIGENS; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; MYELIN PROTEOLIPID PROTEIN; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0031940335     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00252-8     Document Type: Article

References (55)

1. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol. 10:1992;153-187.
2. Steinman L. Multiple sclerosis A coordinated immunological attack against myelin in the central nervous system . Cell. 85:1996;299-302.
3. Baxevanis CN, Reclos GJ, Servis C, Anastasopoulos E, Arsenis P, Katsiyiannis A, Matikas N, Lambris JD, Papamichail M. Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosis. J Neuroimmunol. 22:1989;23-30.
4. + cytolytic T-lymphocyte clones isolated from multiple sclerosis patients. Human Immunol. 22:1988;97-109.
5. Richert JR, Robinson ED, Deibler GE, Martenson RE, Dragovic LJ, Kies MW. Evidence for multiple human T cell recognition sites on myelin basic protein. J Neuroimmunol. 23:1989;55-66.
6. Allegretta M, Nicklas JA, Sriram S, Albertini RJ. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science. 247:1990;718-721.
7. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:1990;183-187.
8. Pette M, Fujita K, Wilkinson D, Altmann DM, Trowsdale J, Giegerich G, Hinkkanen A, Epplen JT, Kappos L, Wekerle H. Myelin autoreactivity in multiple sclerosis Recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors . Proc Natl Acad Sci USA. 87:1990;7968-7972.
9. Martin R, Utz U, Coligan JE, Richert JR, Flerlage M, Robinson E, Stone R, Biddison WE, McFarlin DE, McFarland HF. Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol. 148:1992;1359-1366.
10. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimonkevitz R, Sherritt M, Rothbard J, Bernard CC, Steinman L. Selection for T-cell receptor V beta-D beta- J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 362:1993;68-70.
11. Soderstrom M, Link H, Sun JB, Fredrikson S, Kostulas V, Hojeberg B, Li BL, Olsson T. T cells recognizing multiple peptides of myelin basic protein are found in blood and enriched in cerebrospinal fluid in optic neuritis and multiple sclerosis Scand . J Immunol. 37:1993;355-368.
12. Sun J-B, Olsson T, Wang W-Z, Xiao B-G, Kostulas V, Fredrikson S, Ekre H-P, Link H. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol. 21:1991;1461-1468.
13. Trotter JL, Hickey WF, van der Veen RC, Sulze L. Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides. J Neuroimmunol. 33:1991;55-62.
14. Chou YK, Bourdette DN, Offner H, Whitham R, Wang RY, Hashim GA, Vandenbark AA. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol. 38:1992;105-113.
15. + T cells from multiple sclerosis patients. J Neuroimmunol. 53:1994;153-161.
16. Tuohy VK, Yu M, Weinstock-Guttman B, Kinkel RP. Diversity and plasticity of self-recognition during the development of multiple sclerosis. J Clin Invest. 99:1997;1682-1690.
17. Kerlero de Rosbo N, Milo R, Lees MB, Burger D, Bernard CC, Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein . J Clin Invest. 92:1993;2602-2608.
18. Zhang Y, Burger D, Saruhan G, Jeannet M, Steck AJ. The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis. Neurology. 43:1993;403-407.
19. Francis DA, Thompson AJ, Brookes P, Davey N, Lechler RI, McDonald WI, Batchelor JR. Multiple sclerosis and HLA Is the susceptibility gene really HLA-DR or -DQ? Human Immunol. 32:1991;119-124.
20. Allen M, Sandberg-Wollheim M, Sjogren K, Erlich HA, Petterson U, Gyllensten U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Human Immunol. 39:1994;41-48.
21. Wucherpfennig KW, Weiner HL, Hafler DA. T-cell recognition of myelin basic protein. Immunol Today. 12:1991;277-282.
22. Olerup O, Hillert J, Fredrikson S, Olsson T, Kam-Hansen S, Moller E, Carlsson B, Wallin J. Primarily chronic progressive and relapsing/remitting multiple sclerosis Two immunogenetically distinct disease entities . Proc Natl Acad Sci USA. 86:1989;7113-7117.
23. Morrissey SP, Miller DH, Kendall BE, Kingsley DP, Kelly MA, Francis DA, MacManus DG, McDonald WI. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain. 116:1993;135-146.
24. Filippi M, Horsfield MA, Morrissey SP, MacManus DG, Rudge P, McDonald WI, Miller DH. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology. 44:1994;635-641.
25. Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Eng J Med. 329:1993;1764-1769.
26. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:1992;155-157.
27. McRae BL, Vanderlugt CL, Dal Canto MC Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med. 182:1995;75-85.
28. Yu M, Johnson JM, Tuohy VK. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis A basis for peptide-specific therapy after onset of clinical disease . J Exp Med. 183:1996;1777-1788.
29. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis Guidelines for research protocols . Ann Neurol. 13:1983;227-231.
30. Milner RJ, Lai C, Nave K-A, Lenoir D, Ogata J, Sutcliffe JG. Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell. 42:1985;931-939.
31. Macklin WB, Campagnoni CW, Deininger PL, Gardinier MV. Structure and expression of the mouse myelin proteolipid protein gene. J Neurosci Res. 18:1987;383-394.
32. Novotny J, Bruccoleri RE, Carlson WD, Handschumacher M, Haber E. Antigenicity of myohemerythrin. Science. 238:1987;1584-1586.
33. Folch J, Lees M, Sloane, Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 226:1957;497-509.
34. Tuohy VK, Lu Z, Sobel RA, Laursen RA, Lees MB. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol. 142:1989;1523-1527.
35. Martin R, Jaraquemada D, Flerlage M, Richert J, Whitaker J, Long EO, McFarlin DE, McFarland HF. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol. 145:1990;540-548.
36. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol. 11:1993;729-766.
37. Tuohy VK, Thomas DM. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice. J Neuroimmunol. 56:1995;161-170.
38. 1 mice with acute experimental allergic encephalomyelitis induced with two different synthetic peptides of myelin proteolipid protein. J Immunol. 146:1991;543-549.
39. Valli A, Sette A, Kappos L, Oseroff C, Sidney J, Miescher G, Hochberger M, Albert ED, Adorini L. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest. 91:1993;616-628.
40. Jaraquemada D, Martin R, Rosen-Bronson S, Flerlage M, McFarland HF, Long EO. HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. J Immunol. 145:1990;2880-2885.
41. Ohashi T, Yamamura T, Inobe J, Kondo T, Kunishita T, Tabira T. Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis Identification of PLP 95-116 as an HLA- DR2,w15-associated determinant . Internat Immunol. 7:1995;1771-1778.
42. Pelfrey CM, Trotter JL, Tranquill LR, McFarland HF. Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients. J Neuroimmunol. 46:1993;33-42.
43. Markovic-Plese S, Fukaura H, Zhang J, al-Sabbagh A Southwood S, Sette A, Kuchroo VK, Hafler DA. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J Immunol. 155:1995;982-992.
44. 1 mice. J Immunol. 147:1991;3803-3808.
45. Marrosu MG, Muntoni F, Murru MR, Spinicci G, Pischedda MP, Goddi F, Cossu P, Pirastu M. Sardinian multiple sclerosis is associated with HLA-DR4 A serologic and molecular analysis . Neurology. 38:1988;1749-1753.
46. Yaqub BA, Daif AK. Multiple sclerosis in Saudi Arabia. Neurology. 38:1988;621-623.
47. Naito S, Kuroiwa Y, Itoyama T, Tsubaki T, Horikawa A, Sasazuki T, Noguchi S, Ohtsuki S, Tokuomi H, Miyatake T, Takahata N, Kawanami S. HLA and Japanese MS. Tissue Antigens. 12:1978;19-24.
48. Gorodezky C, Najera R, Rangel BE, Castro LE, Flores J, Velazquez G, Granados J, Sotelo J. Immunogenetic profile of multiple sclerosis in Mexicans. Human Immunol. 16:1986;364-374.
49. Odum N, Hyldig-Nielsen JJ, Morling N, Sandberg-Wollheim M, Platz P, Svejgaard A. HLA-DP antigens are involved in the susceptibility to multiple sclerosis. Tissue Antigens. 31:1988;235-237.
50. Fugger L, Ryder LP, Morling N, Odum N, Friis J, Pedersen FK, Heilmann C, Sandberg-Wollheim M, Svejgaard A. DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis. Immunogenetics. 32:1990;150-156.
51. Olerup O, Hillert J, Fredrikson S. The HLA-D region-associated MS-susceptibility genes may be located telomeric to the HLA-DP subregion. Tissue Antigens. 36:1990;37-39.
52. Erlich HA, Rotter JI, Chang JD, Shaw SJ, Raffel LJ, Klitz W, Bugawan TL, Zeidler A. Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes. 45:1996;610-614.
53. Rihs HP, Conrad K, Mehlhorn J, May-Taube K, Welticke B, Frank KH, Baur X. Molecular analysis of HLA-DPB1 alleles in idiopathic systemic sclerosis patients and uranium miners with systemic sclerosis. Int Arch Allergy Immunol. 109:1996;216-222.
54. Scholz S, Albert ED. Immunogenetic aspects of juvenile chronic arthritis. Clin Exp Rheumat. 11:(suppl 9):1993;s37-s41.
55. Ulvestad E, Williams K, Bo L, Trapp B, Antel J, Mork S. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro. Immunology. 82:1994;535-541.